Advanced Cholangiocarcinoma Treatment Infigratinib Granted Accelerated Approval by FDA
According to a recent article at Pharmacy Times, Infigratinib has been granted accelerated approval for the treatment of those with metastatic cholangiocarcinoma. The treatment is for adults whose cholangiocarcinoma is…